<DOC>
	<DOC>NCT00455884</DOC>
	<brief_summary>This study is a multicenter, open-label, observational, post marketing surveillance program to collect information on the use of NutropinAq® in adults suffering from Growth Hormone Deficiency in Germany, Italy, and United Kingdom</brief_summary>
	<brief_title>A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Patients with Growth Hormone Deficiency Patients treated with NutropinAq® Patients having completed growth (fused epiphyses) Active neoplasia Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>